Positive Results of Clinical Trial Comparing Coherus’ Ranibizumab Biosimilar Candidate CHS-201 to Reference Product Lucentis® (Ranibizumab) in the Treatment of Neovascular (Wet) Age-Related Macular Degeneration (nAMD) Presented at Retina Society Annual Scientific Meeting

Joey Cohen
Medication Adherence

Bud Bilanich
Success Coach

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement

Pat Purcell
Meeting Engagement

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Matthew Durham
Omnidynamic Marketing

Daniel Sontupe
Market Access

Brenda Snow
Authentic Patient Voice

David Linetsky
Point-of-Care Marketing

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

Frank Burrell
Scientific Storytelling